Tribune Pulse - June 21, 2018 - Volume II - Issue 22
The Countdown is on to TTS 2018!
There remains a little over a week to the start of the Congress and many of you have already started your way to Spain to spend an amazing week with your colleagures from around the world.
Not registered yet? You can still register onsite as of June 30!
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation Featured in this month's issue
Transplantation - June 2018 - Volume 102 - Issue 6
The Third TTS CMV Guidelines are released this month defining the current state of knowledge for management of CMV. The issue also contains a summary of the FDA public workshop on ABMR; great papers on liver transplantation especially in pediatrics; and news from the UK on waitlist management; news on islet transplant outcomes and much more...
Medicine for her diabetes kept her alive -- and it was killing her, too
June 12 - There was a nice article featured on CNN last week featuring Raja Kandaswamy from University of Minnesota. This is a nice human interest story.
ISN-TTS Sister Transplant WebinAR Providing TIPS to make your application SHINE
Watch our webinar to get some tips
Sister Centers Programs link renal and transplant centers in low-and-middle income countries with centers of excellence in the developed world. There are now 65 active Sister Centers partnership and 13 of them are focused on transplantation.
The deadline to apply for the ISN Sister Renal Centers Program and the ISN-TTS Sister Transplant Centers Program is set for October 1st, 2018.
Learn to make your application stand out and register for a special webinar to be broadcast on July 12, 2018 between 2PM and 3PM CEST.
Peter Kerr, Chair of the Sister Renal Centers Program, and Philip J. O'Connell, Past-President of The Transplantation Society and Director of Transplantation, will guide you through each step of the application process. They will share some handy tips on how to prepare a successful application and answer any questions you may have.
TTS 2018 - Highlighted Corporate Symposium
TTS 2018 - Madrid - IFEMA Feria de Madrid, Spain
Join us at the Chiesi Symposium on 2nd July, h 16:30-17:30 (Room 103 | North Convention Centre)
Session full program:
Might different patients need different approaches? New concepts on tacrolimus metabolism and pharmacokinetics.
Chaired by Prof. J. Pascual - Spain
- Clinical sensitivity to tacrolimus pharmacokinetics
Prof. R. Oberbauer - Austria
- Tacrolimus fast metabolisers: how to identify them beyond race and genotype
Prof. K. Budde - Germany
Based in Parma, Italy, Chiesi Farmaceutici is an international Healthcare Group, with over 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative drugs in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas. Chiesi has been present in the solid organ transplant area since 2014, and keeps working every day to put its expertise at the service of specialists, to help them find the right immunosuppressive approach for each different transplanted patient.
INTERNATIONAL SOCIETY FOR ORGAN DONATION AND PROCUREMENT (2021)
DEADLINE EXTENDED TO JULY 12
The International Society for Organ Donation and Procurement aims to foster, promote and develop all aspects of organ and tissue donation and procurement. The ultimate aim is to increase the supply of high quality organs and tissue to match patients' need and to promote countries increasing performance towards self-sufficiency and improved opportunity for transplantation.
Every two years, the ISODP Congress brings together clinicians and scientists from all parts of the world in the fields of organ procurement and donation.
Transplantation - Featured Article
Submitted by Dr Andrea Schlegel, Editorial Fellow, Transplantation.
The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation.
Li C-X, Man K, Lo C-M
This excellent review deals with the challenging field of cancer recurrence after liver transplantation. The authors discuss the impact of graft quality and ischaemia/reperfusion injury leading to environmental advantages with relevance for cancer cells to migrate into the transplanted liver. The authors discuss the impact of different graft types, including living related liver donation, livers from donation after circulatory death donors and steatotic grafts. In addition, they provide a detailed discussion on how an impaired endothelial barrier function in combination with hypoxia and sterile inflammation may modify tumour cell adhesion, migration, and invasion. Finally, the authors discuss the role of progenitor and other immune regulatory cells in the modified microenvironment of a liver transplant. Understanding risk factors, consequences and mechanisms of tumor reoccurrence will be critical in implementing novel treatments.
Venoarterial ECMO Improves Survival to Transplant in Interstitial Lung Disease
June 20 - Venoarterial extracorporeal membrane oxygenation (ECMO) improved rates of survival while awaiting lung transplantation in individuals with end-stage interstitial lung disease and pulmonary hypertension (PH), according to a study recently published in The Annals of Thoracic Surgery
Double Lung Transplantation Improves Survival in Interstitial Pulmonary Fibrosis
June 19 - Individuals with pulmonary fibrosis experienced better long-term outcomes with double lung transplantation compared with single lung transplantation up until age 70, according to a study published in The Annals of Thoracic Surgery.
Metabolomics in Organ Transplantation
June 15 - To overcome problems associated with traditional biomarkers and measurement techniques, many studies have been done to authenticate the importance of metabolomics.